Skip to main content

Compass Therapeutics, Inc.

CMPX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001738021

In the last 90 days, Compass Therapeutics, Inc. insiders filed 3 open-market purchases and 0 sales; 171 institutions reported holding it in 13F filings for Q3 2026, worth $167.0M in total; no superinvestor holds it.

Key figures

Market capClose on Nov 18, 2026
$110.0M
Insider buysLast 90 days, $27.1K in total
3
Insider sellsOpen market, last 90 days
0
13F holdersQ3 2026, −40 vs. previous quarter
171
13F valueReported value at the end of Q3 2026
$167.0M
Superinvestors holdingAt the end of Q3 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
$0
−100.0% year over year
Net income, FY2025
-$66.5M
No comparable prior period
Free cash flow, FY2025
-$49.2M
No comparable prior period
Revenue, Q3 FY2026
–
No comparable prior period

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
40.8M
Shares sold short
Change
−1.06M
−2.5% vs. previous
Days to cover
18.93
At average daily volume

Superinvestors holding CMPX, Q3 2026

Go to the superinvestors tab

No superinvestor reported holding CMPX at the end of Q3 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Compass Therapeutics, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 18, 2026 (view filing)8:33 AM ETNov 171 dayLerner NeilChief Accounting OfficerPPurchase+10.0K$0.59+$5.90K+2.4%430.0K after
Oct 2, 2026 (view filing)8:00 AM ETOct 11 dayLerner NeilChief Accounting OfficerPPurchase+20.0K$0.92+$18.4K+5.0%420.0K after
Sep 25, 2026 (view filing)8:01 AM ETSep 241 dayLerner NeilChief Accounting OfficerPPurchase+2.50K$1.14+$2.85K+0.6%400.0K after
Apr 30, 2026 (view filing)Apr 291 dayLerner NeilChief Accounting OfficerPPurchase+15.0K$1.89+$28.4K+3.9%397.5K afterAmended
Apr 30, 2026 (view filing)Apr 291 dayAnderman JonathanGeneral CounselPPurchase+25.0K$1.89+$47.3K+14.6%196.0K afterAmended
May 27, 2025 (view filing)May 27Same daySchuetz Thomas J.CHIEF EXECUTIVE OFFICERPPurchase+10.0K$2.11+$21.1K+0.2%6.48M after
Apr 11, 2025 (view filing)7:24 PM ETApr 92 daysOrbiMed Advisors LLC and 2 othersDirector, 10% OwnerSSale−3.57M$1.59−$5.68M−100.0%0 afterDuplicate filing
Apr 11, 2025 (view filing)Apr 92 daysGordon Carl LDirector, 10% OwnerSSale−3.57M$1.59−$5.68M−100.0%0 after
Apr 8, 2025 (view filing)Apr 71 dayAnderman JonathanGen Counsel & Corporate SecPPurchase+20.0K$1.54+$30.8K+2,000.0%21.0K after
Apr 8, 2025 (view filing)Apr 71 dayLerner NeilCHIEF ACCOUNTING OFFICERPPurchase+20.0K$1.42+$28.4K+6.7%320.0K after

Top 10 13F holders, Q3 2026

See all 171 holders

The largest institutional positions in Compass Therapeutics, Inc. at the end of Q3 2026; share changes are against Q2 2026.

Institutions holding CMPX in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Tang Capital Management LLC17,990,782$18.7M0.86%00.0%Unchanged
OrbiMed Advisors LLC15,219,994$15.8M0.29%00.0%Unchanged
Suvretta Capital Management, LLC14,326,988$14.9M0.41%+225,829+1.6%Added
BlackRock, Inc.11,394,556$11.9M0.00%+112,775+1.0%Added
Enavate Sciences GP, LLC7,788,150$8.10M2.90%00.0%Unchanged
State Street Corp7,737,938$8.05M0.00%−2,215,715−22.3%Reduced
Palo Alto Investors LP7,148,673$7.43M1.11%+1,316,860+22.6%Added
Vanguard Capital Management LLC5,994,782$6.23M0.00%−124,000−2.0%Reduced
Millennium Management LLC4,686,422$4.87M0.00%−26,825−0.6%Reduced
Qube Research & Technologies Ltd4,170,894$4.34M0.00%+483,405+13.1%Added

Holders of 5% or more of CMPX

See all 4 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Compass Therapeutics, Inc..

Largest holders of CMPX from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Tang Capital Management LLC13G/A9.99%17.2M shares0.00 ppfrom 9.99%Jan 16, 20255 filingsNov 14, 2025SEC
OrbiMed Advisors LLC13D/A8.90%15.2M shares−2.10 ppfrom 11.00%Jul 14, 20216 filingsAug 15, 2025SEC
Suvretta Capital Management, LLC13G/A8.20%14.1M shares+3.00 ppfrom 5.20%Aug 13, 20252 filingsAug 21, 2025SEC
BlackRock, Inc.13G5.20%9.27M shares+0.60 ppfrom 4.60%Feb 4, 20253 filingsJan 21, 2026SEC